Inventor

Bruce A. Sullenger

Inventor
Durham, NC, US

Overview

30→
Patents
1997–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes25%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07HSugars9%
C12YEnzymes9%
C07KPeptides6%
A61LMethods or apparatus for sterilising materials or objects in general2%
B29CShaping or joining of plastics2%
D01DMechanical methods or apparatus in the manufacture of artificial filaments, threads, fibres, bristles or ribbons2%
D01FChemical features in the manufacture of artificial filaments, threads, fibres, bristles or ribbons2%
PatentTitleYear
10,889,816Von Willebrand Factor (VWF)--targeting agents and methods of using the same202110,808,335Electrospun cationic nanofibers and methods of making and using the same202010,660,973Thrombus imaging aptamers and methods of using same202010,350,1582' fluoro-modified RNAs as immunostimulators201910,066,323Electrospun cationic nanofibers and methods of making and using the same20189,970,014Factor V/Va-targeting aptamer compositions and methods of using the same20189,901,553'Method of modulating the activity of a nucleic acid molecule'20189,873,727Reversible platelet inhibition20189,861,574'2-fluoro-modified RNAs as immunostimulators'20189,687,529'Method of controlling coagulation'20179,468,650'Inhibition of endosomal toll-like receptor activation'20169,340,591'Method of modulating the activity of a nucleic acid molecule'20169,061,043'Aptamers to glycoprotein VI'20158,790,924'Reversible platelet inhibition'20148,586,524'Modulators of pharmacological agents'20138,367,627'Focused libraries, functional profiling, laser SELEX, and DESELEX'20138,283,330'Modulators of pharmacological agents'20128,143,233'RNA aptamers and methods for identifying the same'20127,858,591'RNA aptamers and methods for identifying the same'20107,812,001'RNA aptamers and methods for identifying the same'20107,776,837'RNA aptamers and methods for identifying the same'20107,776,836'RNA aptamers and methods for identifying the same'20107,741,307'RNA aptamers and methods for identifying the same'20107,312,325'RNA aptamers and methods for identifying the same'20077,300,922'Modulators of pharmacological agents'20077,045,293'Alteration of sequence of a target molecule'20066,897,016'Alteration of sequence of a target molecule'20055,869,254'Alteration of sequence of a target molecule by ribozyme catalyzed trans-splicing'19995,854,038'Localization of a therapeutic agent in a cell in vitro'19985,667,969'Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–1999Patents assigned to UNIV RESEARCH CORP (3)· patent assignee history
1997–2006Based in Westminster, CO, US· patent location history
2007–2021Patents assigned to UNIV DUKE (25)· patent assignee history
2007–2021Based in Durham, NC, US· patent location history
2012–2017Patents assigned to SULLENGER BRUCE A (9)· patent assignee history
2012–2013Patents assigned to RUSCONI CHRISTOPHER P (4)· patent assignee history
2013–2016Patents assigned to ONEY SABAH (3)· patent assignee history
2013Based in Chapel Hill, NC, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV DUKE252007–2021
SULLENGER BRUCE Aself92012–2017
RUSCONI CHRISTOPHER P42012–2013
ONEY SABAH32013–2016
UNIV RESEARCH CORP31997–1999
Locations
LocationPatentsSpan
Durham, NC, US242007–2021
Westminster, CO, US51997–2006
Chapel Hill, NC, US12013